OZONE PHARMACEUTICALS LTD

New Delhi-based Ozone Pharmaceuticals recorded a revenue generation of Rs 20 crore in the biopharma space in FY 20-21, showing a decline in growth by 24 per cent when compared to the revenue generation of Rs 27 crore during FY 19-20. Ozone Pharmaceuticals is a formulation based drug manufacturing and marketing company, with a focus across 14 therapy areas including pain management, nutritional supplements, anti-infective, cardiac, diabetes and hemostats, etc. The company promotes products and brands to 1,00,000+ doctors across India and Nepal.